Ozempic tops new Medicare price negotiation list

As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare Conference in San Francisco, the outgoing Biden administration at HHS dropped their farewell gift to the industry - the list of the next 15 drugs …

HHS expands Medicare drug price negotiations to add 15 medications

The US Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), today announced a significant step forward in reducing prescription drug costs for Medicare beneficiaries. The agency has selected 15 …

Medicare Part D Phase 2 Price Negotiations Target Semaglutide (Wegovy) Plus 14 More

Ozempic (semaglutide), the type 2 diabetes (T2D) drug that has become popular for weight loss, and Wegovy, the form of the drug approved for individuals with obesity or overweight, are on the list for Medicare drug price negotiations in 2025. Rybelsus, the …

Ozempic, Wegovy included in next round of Medicare price negotiations with drug makers

Fifteen new drugs including the Ozempic will be included in Medicare's next round of price negotiation with drug makers, the Biden administration announced Friday. Ozempic, used to treat Type 2 diabetes and obesity, is manufactured by Novo Nordisk. …

How long does it take to get Medicare Part B after applying? Find out the estimated waiting period

When applying for Medicare Part B, understanding the estimated waiting period is essential for effective healthcare planning. The standard processing time for Medicare Part B applications typically ranges from one to three months after the Social Security …

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations

On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on efforts to reduce prescription drug costs. These negotiations, mandated by the …

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

The Biden administration unveiled the next 15 prescription drugs that will be subject to price negotiations between manufacturers and Medicare. It kicks off the second phase of a landmark provision in the Inflation Reduction Act that aims to make costly …

Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiations

Ozempic and Wegovy among drugs on Medicare list getting price cuts

By Ike Swetlitz and Damian Garde | Bloomberg The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more than $200 billion …

Novo's Ozempic, Wegovy targeted for medicare price cuts

The U.S. plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that's expected to save the government more than $200 billion over a decade.  Novo's …